These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19475556)

  • 1. Dielectric relaxation study on tramadol monohydrate and its hydrochloride salt.
    Kaminski K; Kaminska E; Adrjanowicz K; Grzybowiska K; Wlodarczyk P; Paluch M; Burian A; Ziolo J; Lepek P; Mazgalski J; Sawicki W
    J Pharm Sci; 2010 Jan; 99(1):94-106. PubMed ID: 19475556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dielectric relaxation studies and dissolution behavior of amorphous verapamil hydrochloride.
    Adrjanowicz K; Kaminski K; Paluch M; Wlodarczyk P; Grzybowska K; Wojnarowska Z; Hawelek L; Sawicki W; Lepek P; Lunio R
    J Pharm Sci; 2010 Feb; 99(2):828-39. PubMed ID: 19593787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy.
    Kaminski K; Adrjanowicz K; Wojnarowska Z; Grzybowska K; Hawelek L; Paluch M; Zakowiecki D; Mazgalski J
    J Pharm Sci; 2011 Jul; 100(7):2642-57. PubMed ID: 21271564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction.
    Sawicki W; Mazgalski J; Jakubowska I
    Drug Dev Ind Pharm; 2010 Feb; 36(2):209-17. PubMed ID: 20070185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new formulation and its evaluation by capillary electrophoresis of tablets containing tramadol hydrochloride and paracetamol.
    Ciurba A; Hancu G; Cojocea LM; Sipos E; Todoran N
    Pharm Dev Technol; 2014 Nov; 19(7):833-8. PubMed ID: 24028179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength.
    Madgulkar AR; Bhalekar MR; Padalkar RR
    AAPS PharmSciTech; 2009; 10(2):574-81. PubMed ID: 19440844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol loading, release and iontophoretic characteristics of ion-exchange fiber.
    Gao Y; Yuan J; Liu H; Yang Y; Hou Y; Li S
    Int J Pharm; 2014 Apr; 465(1-2):102-11. PubMed ID: 24530391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material.
    Wojnarowska Z; Grzybowska K; Adrjanowicz K; Kaminski K; Paluch M; Hawelek L; Wrzalik R; Dulski M; Sawicki W; Mazgalski J; Tukalska A; Bieg T
    Mol Pharm; 2010 Oct; 7(5):1692-707. PubMed ID: 20669906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PREDICTIVE PHARMACOKINETICS OF TRAMADOL HYDROCHLORIDE FLOATING TABLETS.
    Wang J; Zhang Y; Guo Z; Tao Q; Wang Y; Zhou W; Ma X; Li Z
    Acta Pol Pharm; 2016; 73(3):755-9. PubMed ID: 27476294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the Physical Stability of Amorphous Tenapanor Hydrochloride Using Local Molecular Structure Analysis, Relaxation Time Constants, and Molecular Modeling.
    Kothari S; Vippagunta RR
    Mol Pharm; 2019 Mar; 16(3):943-951. PubMed ID: 30699296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.